Summary of Department
A wide range of specialized medical treatments have been established for blood diseases commonly encountered in daily medical care, such as anemia and thrombocytopenia, as well as hematological malignancies, such as leukemia, myelodysplastic syndrome, malignant lymphoma and multiple myeloma. Hematological malignancies are mainly treated with anticancer drugs, and we are also trained in specialized treatment methods, such as bone marrow, peripheral blood stem cell, and cord blood transplants. We are currently focusing on the treatment of ATL (Adult T-cell leukemia/lymphoma) by mainly conducting allogenic hematopoietic transplantations and carrying out clinical trials or performing chemotherapy. The entire hematology ward has 48 beds in a germ-free environment, including 10 beds for hematopoietic stem cell transplants.
In order to improve treatment outcomes, we are now conducting several clinical trials on new drugs, including global studies, that are strongly expected to prove effective in order to meet the needs of our patients.
As treatment for hematological malignancies is often conducted over a long period of time, we treat our patients in cooperation with a large medical team of rehabilitation experts, psychotherapists, dieticians and social workers as well as hematology specialist doctors, nurses and pharmacists. Our hospital has been certified as a training facility of the Japanese Society of Hematology, and under the guidance of hematology specialists and instructors, we are focusing on developing skills in young doctors who will lead the next generation.
